LSI.F CK Life Sciences Int'l. (Holdings) Inc

Healthcare Biotechnology Frankfurt Exchange
0.0605 EUR
Close of Nov 12, 2026
0.0545 0.0960
Market cap
EUR 581M
P/E
-
P/B
1.28x
ROE
-4.9%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2025.

Is LSI.F undervalued?

Graham number

The Graham number of CK Life Sciences Int'l. (Holdings) Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

CK Life Sciences Int'l. (Holdings) Inc fundamental analysis

No fundamental analysis for CK Life Sciences Int'l. (Holdings) Inc yet.

CK Life Sciences Int'l. (Holdings) Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About CK Life Sciences Int'l. (Holdings) Inc

CK Life Sciences Int'l., (Holdings) Inc., an investment holding company, researches, develops, manufactures, commercializes, and sells health and agriculture-related products in the Asia Pacific and North America. It manufactures and markets plant protection products and soluble fertilizers; manufactures, blends, distributes, trades, and sells fertilizers, pesticides, and related agricultural products; manufactures and distributes horticultural products for the home gardenin…

Full company profile